Mine-Hsine Wu

468 total citations
11 papers, 357 citations indexed

About

Mine-Hsine Wu is a scholar working on Molecular Biology, Biological Psychiatry and Pharmacology. According to data from OpenAlex, Mine-Hsine Wu has authored 11 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Biological Psychiatry and 3 papers in Pharmacology. Recurrent topics in Mine-Hsine Wu's work include Tryptophan and brain disorders (4 papers), Pharmacological Receptor Mechanisms and Effects (2 papers) and Microtubule and mitosis dynamics (2 papers). Mine-Hsine Wu is often cited by papers focused on Tryptophan and brain disorders (4 papers), Pharmacological Receptor Mechanisms and Effects (2 papers) and Microtubule and mitosis dynamics (2 papers). Mine-Hsine Wu collaborates with scholars based in Taiwan. Mine-Hsine Wu's co-authors include Jen‐Shin Song, Chuan Shih, Shau‐Hua Ueng, Su‐Ying Wu, Ming‐Shiu Hung, Wen‐Chi Hsiao, Shu‐Yu Lin, Jian‐Sung Wu, Yi‐Hui Peng and Shiu‐Hwa Yeh and has published in prestigious journals such as Scientific Reports, Journal of Medicinal Chemistry and RSC Advances.

In The Last Decade

Mine-Hsine Wu

11 papers receiving 354 citations

Peers

Mine-Hsine Wu

PMH

CTM

Alice Coletti Italy

Chunhong Yan United States

Somi Reddy Majjigapu Switzerland

Leeanne Zalameda United States

Erica C. VanderPorten United States

Krishna Praneeth Kilambi United States

Mayukh Chakrabarti United States

Magnús Haraldsson Iceland

Petr Kočiš United States

Haydn T. Jones United Kingdom

Alice Coletti Italy

Mine-Hsine Wu

181 ×1.0

176 ×1.0

71 ×0.8

PMH

16 ×0.2

CTM

28 ×0.5

Citations per year, relative to Mine-Hsine Wu Mine-Hsine Wu (= 1×) peers Alice Coletti

Countries citing papers authored by Mine-Hsine Wu

Since Specialization

Citations

This map shows the geographic impact of Mine-Hsine Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mine-Hsine Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mine-Hsine Wu more than expected).

Fields of papers citing papers by Mine-Hsine Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mine-Hsine Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mine-Hsine Wu. The network helps show where Mine-Hsine Wu may publish in the future.

Co-authorship network of co-authors of Mine-Hsine Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Mine-Hsine Wu. A scholar is included among the top collaborators of Mine-Hsine Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mine-Hsine Wu. Mine-Hsine Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Chang, Chun‐Ping, Teng‐Kuang Yeh, Chiung‐Tong Chen, et al.. (2024). Discovery of a Long Half-Life AURKA Inhibitor to Treat MYC-Amplified Solid Tumors as a Monotherapy and in Combination with Everolimus. Molecular Cancer Therapeutics. 23(6). 766–779. 4 indexed citations

Wang, Jingya, Wan-Ping Wang, Wei‐Cheng Huang, et al.. (2023). Analysis of structure–activity relationship of indol-3-yl-N-phenylcarbamic amides as potent STING inhibitors. Bioorganic & Medicinal Chemistry. 95. 117502–117502. 6 indexed citations

Wu, Mine-Hsine, et al.. (2023). Design, synthesis, and anticancer evaluation of 1-benzo[1,3]dioxol-5-yl-3-N-fused heteroaryl indoles. Molecular Diversity. 28(2). 595–608. 2 indexed citations

Wu, Mine-Hsine, I‐Wen Huang, Tsai-Ling Yang Lauderdale, et al.. (2021). Total synthesis of landomycins Q and R and related core structures for exploration of the cytotoxicity and antibacterial properties. RSC Advances. 11(16). 9426–9432. 5 indexed citations

Chi, Ya‐Hui, Teng‐Kuang Yeh, Yi‐Yu Ke, et al.. (2021). Discovery and Synthesis of a Pyrimidine-Based Aurora Kinase Inhibitor to Reduce Levels of MYC Oncoproteins. Journal of Medicinal Chemistry. 64(11). 7312–7330. 15 indexed citations

Tsou, Lun K., Shiu‐Hwa Yeh, Shau‐Hua Ueng, et al.. (2020). Comparative study between deep learning and QSAR classifications for TNBC inhibitors and novel GPCR agonist discovery. Scientific Reports. 10(1). 16771–16771. 71 indexed citations

Peng, Yi‐Hui, Ramajayam Kuppusamy, Mine-Hsine Wu, et al.. (2020). Unique Sulfur–Aromatic Interactions Contribute to the Binding of Potent Imidazothiazole Indoleamine 2,3-Dioxygenase Inhibitors. Journal of Medicinal Chemistry. 63(4). 1642–1659. 31 indexed citations

Song, Jen‐Shin, Szu‐Huei Wu, Lun K. Tsou, et al.. (2018). Development of Stem-Cell-Mobilizing Agents Targeting CXCR4 Receptor for Peripheral Blood Stem Cell Transplantation and Beyond. Journal of Medicinal Chemistry. 61(3). 818–833. 10 indexed citations

Wu, Jian‐Sung, Shu‐Yu Lin, Wen‐Chi Hsiao, et al.. (2015). Identification of Substituted Naphthotriazolediones as Novel Tryptophan 2,3-Dioxygenase (TDO) Inhibitors through Structure-Based Virtual Screening. Journal of Medicinal Chemistry. 58(19). 7807–7819. 48 indexed citations

10.

Peng, Yi‐Hui, Shau‐Hua Ueng, Ming‐Shiu Hung, et al.. (2015). Important Hydrogen Bond Networks in Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Design Revealed by Crystal Structures of Imidazoleisoindole Derivatives with IDO1. Journal of Medicinal Chemistry. 59(1). 282–293. 121 indexed citations

11.

Hung, Ming‐Shiu, Jen‐Shin Song, Shu‐Yu Lin, et al.. (2014). Discovery and structure–activity relationships of phenyl benzenesulfonylhydrazides as novel indoleamine 2,3-dioxygenase inhibitors. Bioorganic & Medicinal Chemistry Letters. 24(15). 3403–3406. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact